# Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease

> **NCT03065192** · PHASE1 · COMPLETED · sponsor: **Neurocrine Biosciences** · enrollment: 16 (actual)

## Conditions studied

- Idiopathic Parkinson's Disease
- Parkinson's Disease
- Basal Ganglia Disease
- Brain Diseases
- Central Nervous System Diseases
- Movement Disorders
- Nervous System Diseases
- Neurodegenerative Diseases
- Parkinsonian Disorders

## Interventions

- **DRUG:** VY-AADC01

## Key facts

- **NCT ID:** NCT03065192
- **Lead sponsor:** Neurocrine Biosciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-11
- **Primary completion:** 2021-08-10
- **Final completion:** 2021-08-10
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2022-03-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03065192

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03065192, "Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03065192. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*